Universal Health Services, Inc. Class B (UHS)

UHS's stock has been impacted by several key events in the past six months. In Q3 CY2025, UHS reported strong results, surpassing revenue expectations with a 13.4% year-on-year sales increase to $4.50 billion, and an adjusted profit of $5.69 per share, leading to an increased full-year revenue guidance for 2025 to $17.38 billion and an increased full-year Adjusted EPS guidance to $21.80, along with a $1.5 billion increase to its stock repurchase program authorization. During Q3 2025, acute care hospitals saw a 2.0% increase in adjusted admissions and a 0.4% increase in adjusted patient days, with net revenue per adjusted admission increasing by 9.8% and net revenue per adjusted patient day increasing by 11.5%; in the behavioral health care segment, adjusted admissions increased by 0.5% and adjusted patient days by 1.3%, with net revenue per adjusted admission up 8.8% and net revenue per adjusted patient day up 7.9%. As of October 2025, analyst ratings for UHS were mixed, with 8 buy, 10 hold, and 1 sell recommendation, and an average target price of $224.19. As of July 31, 2025, UHS's stock price was $166.45, with a 52-week range of $152.33 - $243.25.

There is an indication of consistent demand for UHS's products and services, with increased adjusted admissions and patient days in both acute care and behavioral health segments during Q3 2025 compared to Q3 2024, suggesting a steady or growing demand for hospital and healthcare services, influenced by healthcare policies and an aging demographic. Specific seasonal fluctuations in demand for UHS's services are not explicitly detailed.

Universal Health Services, Inc. (UHS) is a Fortune 300 company providing hospital and healthcare services, operating in the Healthcare sector, primarily in Hospitals/Inpatient Services and Medical Care Facilities industries, with a significant presence in Psychiatric Hospitals. The company owns and operates acute care hospitals, outpatient facilities, and behavioral health care facilities. UHS offers acute care hospital services, including general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, and pediatric services, operating 29 acute care hospitals. UHS is a leading provider of mental health services, operating 331 behavioral health inpatient facilities, offering inpatient psychiatric care and outpatient therapy. The company operates 27 outpatient facilities and ambulatory care centers, along with 33 freestanding emergency departments. UHS offers health insurance plans through Prominence Health and manages physician services through Independence Physician Management, also providing ancillary services like rehabilitation.

Universal Health Services, Inc. operates in 39 states across the U.S., Washington, D.C., Puerto Rico, and the United Kingdom.

Universal Health Services has maintained a strong reputation, being named on the Fortune World's Most Admired List from 2020-2025 and recognized on the Forbes Global 2000 ranking in 2025, ranking #1,090 overall, #355 among U.S. companies, and #23 in the global Health Care Equipment and Services category, earning "Hall of Fame" status in 2023.

86.05% of Universal Health Services, Inc. stock is owned by institutional investors and hedge funds. Convergence Investment Partners LLC reduced its position by 32.1% in Q2 2025, owning 3,777 shares. Other firms like Zions Bancorporation National Association UT, Federated Hermes Inc., Farther Finance Advisors LLC, Harvest Fund Management Co. Ltd, and Reyes Financial Architecture Inc. have either acquired new stakes or boosted their positions in UHS shares during Q1 and Q2 2025.